ConductScience.org, home

Paper3137773

The effect of 1 alpha-hydroxyvitamin D3 on the mineralization defect in disodium etidronate-treated Paget's disease--a double-blind randomized clinical study.

Ralston SH and 6 others. J Bone Miner Res, 1987. Cited by 26 papers, by iCite.

Cite this record

ConductScience Library. The effect of 1 alpha-hydroxyvitamin D3 on the mineralization defect in disodium etidronate-treated Paget's disease--a double-blind randomized clinical study. Papers, record 3137773. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3137773

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The effect of 1 alpha-hydroxyvitamin D3 on the mineralization defect in disodium etidronate-treated Paget's disease--a double-blind randomized clinical study.
PubMed
Journal
J Bone Miner Res
PubMed
Year
1987
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
1.01
iCite
Revised in PubMed
2013-11-21
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ralston SHS H
2Boyce BFB F
3Cowan RAR A
4Fogelman II
5Smith MLM L
6Jenkins AA
7Boyle ITI T

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CalcitriolMajor topic
Etidronic AcidMajor topic
MineralsMajor topic
Osteitis DeformansMajor topic
Alkaline Phosphatase
Creatinine
Double-Blind Method
Humans
Hydroxyproline
Random Allocation

Source PubMed

Download CSV of topics

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
32714279A Clinical Perspective on Advanced Developments in Bone Biopsy Assessment in Rare Bone Disorders.Front Endocrinol (Lausanne)2020https://conductscience.org/library/papers/32714279PubMed
32115673Clinical features, diagnosis and treatment of Paget's disease of bone in mainland China: A systematic review.Rev Endocr Metab Disord2020https://conductscience.org/library/papers/32115673PubMed
30803025Diagnosis and Management of Paget's Disease of Bone in Adults: A Clinical Guideline.J Bone Miner Res2019https://conductscience.org/library/papers/30803025PubMed
29192423Bisphosphonates for Paget's disease of bone in adults.Cochrane Database Syst Rev2017https://conductscience.org/library/papers/29192423PubMed
16937267Guidelines for diagnosis and management of Paget's disease of bone in Japan.J Bone Miner Metab2006https://conductscience.org/library/papers/16937267PubMed
2078998Advances in the management of Paget's disease of bone.Drugs1990https://conductscience.org/library/papers/2078998PubMed
1790405Effect of cyclical therapy with phosphorus and etidronate on axial bone mineral density in postmenopausal osteoporotic women.Osteoporos Int1991https://conductscience.org/library/papers/1790405PubMed
1624597Histological and electron microprobe studies of mineralisation in aluminium-related osteomalacia.J Clin Pathol1992https://conductscience.org/library/papers/1624597PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3137773

GET https://conductscience.org/api/papers/v1/3137773/authors